Loading
Phone :
+1 (858) 366 - 8608
Address :
NovaRhythm Biosciences, Inc
9311 SE Maricamp Rd #1007
Ocala, FL 34472 USA
Email :
info@novarhythmbio.com

Partnership

Value Proposition For Partners & Investors

SAR 29789871 represents a De-Risked, Mechanism-Driven Opportunity in a Major Cardiovascular Market.


  • – Validated Biology: TASK-1 upregulation and atrial      action potential shortening documented in AF.
  • – Advanced Molecule: Significant historical investment and data generation by a major pharma originator.
  • – Clear Clinical Path: IND → Phase 1 safety/PK → Phase 2 efficacy AF.
  • – Strategic Flexibility: Options ranging from co-development partnerships to potential asset or company-level transactions after key inflection points.
  •  

Partening With NovaRhythm

 

NovaRhythm is actively engaging with strategic partners, investors, and clinical collaborators who share our commitment to transforming care in cardiac arrhythmias, in particular atrial fibrillation.

 

  • Industry Partners:
    NovaRhythm is seeking the next industry partners to drive the development of life saving anti-arrhythmic drugs.Please contact: info@novarhythmbio.com 
  • Investment Partners:
    NovaRhythm is actively seeking equity investment partners for IND & Phase 1 studies.
    Please contact: 
    investors@novarhythmbio.com
  •  
  •  

Request Additional Materials

NovaRhythm provides its investor deck and related materials upon request.


Please complete the form below to request access. A member of the NovaRhythm team will follow up directly.







    Investor Type